+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Convalescent Plasma Therapy Market Report 2025 - Product Thumbnail Image

Convalescent Plasma Therapy Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Plasma Therapy Market Report 2025 - Product Thumbnail Image

Plasma Therapy Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Blood Coagulation Factor Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Blood Coagulation Factor Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
From
From
Loading Indicator